T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis

scientific article published on December 2008

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.181.12.8784
P932PMC publication ID2700300
P698PubMed publication ID19050300
P5875ResearchGate publication ID23563337

P50authorAnders EklundQ38084995
Johan GrunewaldQ89669834
P2093author name stringYing Zhang
Edward S Chen
Jan Wahlström
David R Moller
John F McDyer
Rex C Yung
Erin E West
Zhimin Song
Matthew H Willett
Maria Wikén
P2860cites workSex-specific manifestations of Löfgren's syndromeQ24684067
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseasesQ28131652
Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic SocietyQ28139982
Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosisQ28486741
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesQ29547871
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisQ29615201
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitisQ29619339
Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosisQ33212651
Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosisQ33892960
CD4 T-cell memory can persist in the absence of class II.Q33905248
Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative responseQ33942552
In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosisQ34001320
Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.Q34006455
Restraining mycobacteria: role of granulomas in mycobacterial infections.Q34007438
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cellsQ34082942
Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.Q34119135
Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunizationQ34120343
Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosisQ34190079
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosisQ34627050
Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysisQ34632868
Target organ localization of memory CD4(+) T cells in patients with chronic beryllium diseaseQ34826168
T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patientsQ35335795
Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosisQ35591034
Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosisQ35689007
CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotypeQ35828831
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosisQ36099412
Understanding the generation and function of memory T cell subsetsQ36123230
Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosisQ36157413
Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluidQ36220957
The immune paradox of sarcoidosis and regulatory T cellsQ36228289
T cell memory. Long-term persistence of virus-specific cytotoxic T cellsQ36356494
Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patientsQ36437443
Cell damage and autoimmunity: a critical appraisalQ36440448
Sarcoidosis--immunopathogenetic conceptsQ36748168
Epidemiology of sarcoidosis: recent advances and future prospectsQ36748176
Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formationQ36914851
Etiology of sarcoidosisQ37186100
Induction and effector functions of T(H)17 cells.Q37194494
Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosisQ37654644
Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.Q39581695
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cellsQ40163989
Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosisQ40546248
The role of infection in the pathogenesis of autoimmune diseaseQ40640041
Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosisQ40993977
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivoQ42820614
Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.Q43039389
Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysisQ44219049
Clinical characteristics of patients in a case control study of sarcoidosisQ44248269
Expression and immune recognition of stress proteins in sarcoidosis and other chronic interstitial lung diseasesQ45170763
Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapyQ45749203
Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosisQ45856403
Superinfecting mycobacteria home to established tuberculous granulomasQ47281542
Strain variation in the katG region of Mycobacterium tuberculosisQ48078851
Increased CD45RO expression on T lymphocytes in mediastinal lymph node and pulmonary lesions of patients with pulmonary sarcoidosis.Q52058670
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.Q52135468
Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis.Q52890478
Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.Q54546320
Statement on SarcoidosisQ56212262
Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosisQ61317172
Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3Q67513102
Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosisQ68026331
Tuberculosis in patients with various HLA phenotypesQ68599366
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activityQ70550365
Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis CQ71511927
Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993Q72020349
TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosisQ72727523
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosisQ72784636
Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosisQ73086301
Analysis of responses of peripheral blood lymphocytes from sarcoidosis patients to purified protein derivativeQ73544401
Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosisQ73562482
Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous responseQ73705713
Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markersQ73885923
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppressionQ73977252
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatmentQ74844612
Involvement of T cells and alterations in T cell receptors in sarcoidosisQ77386741
The role of mycobacteria in the pathogenesis of sarcoidosisQ77386746
Genetics of sarcoidosisQ79849956
Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controlsQ80409722
Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipientsQ82459210
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)8784-8796
P577publication date2008-12-01
P1433published inJournal of ImmunologyQ3521441
P1476titleT cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis
P478volume181

Reverse relations

cites work (P2860)
Q24609077A concise review of pulmonary sarcoidosis
Q91636353Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease
Q36321921Alveolar macrophage cathelicidin deficiency in severe sarcoidosis
Q37177491An update on granulomatous diseases of the oral tissues
Q38818458Biologic therapies in the treatment of sarcoidosis
Q28384246Carbon Nanotubes and Chronic Granulomatous Disease
Q37333443Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis
Q37446493Dendritic cells in the pathogenesis of sarcoidosis
Q35666895Development of a T7 Phage Display Library to Detect Sarcoidosis and Tuberculosis by a Panel of Novel Antigens.
Q34626531Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide
Q47639676Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: An imaging-based approach. Part 1.
Q39556412Disseminated Mycobacterium tuberculosis Infection Masquerading as Metastasis after Heavy Ion Radiotherapy for Prostate Cancer
Q30459786Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL.
Q33745427Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells
Q37593534Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis
Q38378282Etiologies of Sarcoidosis
Q37887347Evidence for mycobacteria in sarcoidosis
Q47233198Genetic, Immunologic, and Environmental Basis of Sarcoidosis
Q26863703Granuloma formation in pulmonary sarcoidosis
Q57536972HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis
Q37618643High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis
Q51714687Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome.
Q64228485Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis
Q35708762Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro
Q38384482Immunogenetics of Disease-Causing Inflammation in Sarcoidosis
Q47117784Immunohistochemical Detection of Propionibacterium acnes in the Retinal Granulomas in Patients with Ocular Sarcoidosis.
Q54392332Inflammatory markers and pulmonary granuloma infiltration in sarcoidosis.
Q42706504Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis
Q40068151Microbial Lineages in Sarcoidosis: A Metagenomic Analysis Tailored for Low Microbial Content Samples.
Q37088279Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets.
Q34393309Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis
Q39743884Mycobacterium tuberculosis as a sarcoid factor? A case report of family sarcoidosis
Q88140463Neuro-ophthalmic sarcoidosis
Q34128472No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis
Q98237815Novel protein pathways in development and progression of pulmonary sarcoidosis
Q35200674Ocular sarcoidosis and tuberculous lymphadenopathy: coincidence or real association
Q40562122Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation
Q36257697Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
Q38987225Pulmonary sarcoidosis: an update
Q53915829Quantiferon test for tuberculosis screening in sarcoidosis patients.
Q23911842Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol
Q36489305Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study
Q36864267Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis
Q37810386Review Series: Aspects of Interstitial lung disease: Sarcoidosis
Q37756162Review for disease of the year: immunopathogenesis of ocular sarcoidosis
Q41168855Sarcoid lung.
Q95565170Sarcoidosis
Q37363567Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression
Q34344620Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.
Q40884200Sarcoidosis following Mycobacterium tuberculosis infection: Coincidence or consequence
Q36972306Sarcoidosis in tuberculosis-endemic regions: India
Q34199947Sarcoidosis--scientific progress and clinical challenges
Q33658762Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.
Q36199050T7 Phage Display Library a Promising Strategy to Detect Tuberculosis Specific Biomarkers
Q38311906Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?
Q36320544The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis
Q64092272The composition of the pulmonary microbiota in sarcoidosis - an observational study
Q57283960The continuing search for Mycobacterium tuberculosis involvement in sarcoidosis: a study on archival biopsy specimens
Q37841238The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques
Q53310412Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.
Q91622811Translational research in pulmonary fibrosis
Q38828632Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?

Search more.